Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap25.20K
Market cap25.20K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.22
52 Week high$5.22
52 Week low$0.65
52 Week low$0.65
Stock Snapshot
The current Syros Pharmaceuticals(SYRS) stock price is $0.00, with a market capitalization of 25.2K.
On 2026-09-30, Syros Pharmaceuticals(SYRS) stock opened at —, reached a high of —, and a low of —.
The Syros Pharmaceuticals(SYRS)'s current trading volume is 0, compared to an average daily volume of 5.31M.
In the last year, Syros Pharmaceuticals(SYRS) shares hit a 52-week high of $5.22 and a 52-week low of $0.65.
In the last year, Syros Pharmaceuticals(SYRS) shares hit a 52-week high of $5.22 and a 52-week low of $0.65.
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.